StockData
Enveric Biosciences, Inc. logo

Enveric Biosciences, Inc. (ENVB) stock

ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/30
$1.52+0.03 (+2.01%)

Close on Nov 12, 2026Market cap $6.80MP/E –Yield –

Enveric Biosciences statistics

61 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Nov 13, 2026 (estimated, during market hours)
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$6.80M
$280.48M
Enterprise Value
-$1.49M
$148.62M
PB Ratio
0.84
2.05
P/TBV Ratio
0.84
2.29

Share statisticsIndustry

Shares Change (YoY)
1278.9%
10.9%
Shares Change (QoQ)
108.5%
0.48%
Float
3M
49M
Shares Held by Insiders
41.0%
12.1%
Shares Held by Institutions
11.8%
56.4%

Short sellingIndustry

Short Interest
19,617
–
Short Interest Change
-49.3%
-0.76%
Short % of Float
0.74%
9.06%
Short % of Shares Outstanding
0.44%
6.30%
Days to Cover
1.00
5.13

Stock price statisticsIndustry

52-Week High
$13.25
–
52-Week Low
$1.17
–
20-Day Moving Average
$1.45
–
50-Day Moving Average
$1.47
–
200-Day Moving Average
$1.90
–
Average True Range (14)
$0.10
–
Price Change (1 Week)
8.57%
1.51%
Price Change (1 Month)
10.9%
-2.37%
Price Change (3 Months)
-0.98%
-21.1%
Price Change (6 Months)
-33.6%
-22.8%
Price Change (YTD)
-58.1%
-22.6%
Price Change (1 Year)
-74.4%
-21.0%
Price Change (3 Years)
-100.0%
-24.8%
Price Change (5 Years)
-100.0%
-76.9%
Price Change (10 Years)
-100.0%
-63.2%
Average Volume (10 Days)
27,065
–
Average Volume (20 Days)
32,344
–
Average Volume (90 Days)
86,530
–
Relative Volume
0.37
0.80
Relative Strength Index (14)
56.6
44.7
Volatility (1 Year)
160.8%
80.2%
Beta (5 Years)
1.16
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-170.0%
-51.3%
Return on Assets (ROA)
-139.7%
-40.7%
Return on Capital Employed (ROCE)
-108.0%
-38.1%

Financial positionIndustry

Current Ratio
10.21
3.31
Quick Ratio
9.63
2.41

EfficiencyIndustry

Profits Per Employee
-$1.75M
-$683.67K
Employee Count
5
75
WACC
10.7%
10.0%

Income statement (TTM)Industry

Operating Income
-$8.73M
-$20.99M
Pretax Income
-$8.73M
-$13.23M
Net Income
-$8.73M
-$21.61M
EBITDA
-$8.57M
-$16.85M
EPS (Diluted)
-$18.77
-$0.75

Balance sheetIndustry

Net Cash (Debt)
$8.30M
$16.98M
Net Cash Per Share
$1.85
$0.72
Equity (Book Value)
$8.08M
$52.68M
Book Value Per Share
$1.81
$1.50
Tangible Book Value
$8.08M
$26.74M
Working Capital
$7.93M
$78.52M

Cash flow (TTM)Industry

Operating Cash Flow
-$8.56M
-$12.27M

Dividends and yieldsIndustry

Earnings Yield
-128.3%
-21.0%

Scores and fair valueIndustry

Altman Z-Score
-16.12
0.26
Piotroski F-Score
4
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodENVBS&P 500DifferenceENVB per yearS&P 500 per year
1 month+3.4%-2.7%+6.1 pts
3 months-1.9%-1.7%−0.2 pts
Year to date-58.1%+11.9%−70.0 pts
1 year-74.6%+12.0%−86.6 pts
3 years-100.0%+78.2%−178.1 pts-92.9%+21.2%
5 years-100.0%+73.2%−173.2 pts-90.9%+11.6%
10 years-100.0%+309.6%−409.6 pts-83.3%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M ENVB shares were sold short on Oct 30, 2026, down 49.3% from the previous report, or 0.74% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 31.7% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202619,617-49.3%35,1701.0
Oct 15, 202638,702+150.7%73,4791.0
Sep 30, 202615,435-32.5%80,5911.0
Sep 15, 202622,872+77.7%44,9641.0
Aug 31, 202612,873-25.4%159,5381.0
Aug 14, 202617,262-9.7%115,6771.0
Jul 31, 202619,113+3.2%140,4861.0
Jul 15, 202618,513+18.1%77,7111.0
Jun 30, 202615,675-66.2%142,7011.0
Jun 15, 202646,331+74.3%270,1361.0
May 29, 202626,583-77.1%194,7651.0
May 15, 2026115,974-86.9%402,8181.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?